Previously treated Small Lymphocytic Lymphoma (SLL)
Showing 9951 - 9975 of >10,000
Locally Advanced or Metastatic NSCLC Trial in Shanghai (WJ13404 tablets)
Recruiting
- Locally Advanced or Metastatic NSCLC
- WJ13404 tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Dec 14, 2022
NSCLC Trial in Jacksonville (Peripherally located lung tumor, Centrally located lung tumor)
Completed
- Non-Small Cell Lung Cancer
- Peripherally located lung tumor
- Centrally located lung tumor
-
Jacksonville, FloridaUniversity of Florida Proton Therapy Institute
Mar 23, 2022
Generation of Heart Muscle Cells From Blood or Skin Cells of
Recruiting
- Breast Cancer
- skin punch biopsy
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 1, 2022
Human Papillomavirus Infection Trial in Montreal (HPV vaccine, Gardasil 9, Hepatitis A vaccine)
Active, not recruiting
- Human Papillomavirus Infection
- HPV vaccine, Gardasil 9
- Hepatitis A vaccine
-
Montreal, Quebec, CanadaMcGill University - Division of Cancer Epidemiology
Oct 20, 2022
Hypertension Trial in Split (Cannabidiol, Placebo)
Active, not recruiting
- Hypertension
- Cannabidiol
- Placebo
-
Split, CroatiaUniversity of Split School of medicine
Apr 25, 2022
NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose
Recruiting
- Non-small Cell Lung Cancer
- Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
- Low dose cyclophosphamide
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jan 17, 2022
Anemia Trial in Baltimore (HBOC-201)
Available
- Anemia
- HBOC-201
-
Baltimore, MarylandThe Johns Hopkins Hospital
Sep 27, 2021
Colorectal Cancer, Hepatic Metastases Trial in Tours (radiation, other, drug)
Completed
- Colorectal Cancer
- Hepatic Metastases
- MRI
- +3 more
-
Tours, FranceService d'Hépatogastro-entérologie CHRU de TOURS
Jan 6, 2023
Endometriosis Trial in Saint-Denis, Saint-Pierre (PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose)
Not yet recruiting
- Endometriosis
- PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose) (radiolabel)
-
Saint-Denis, France
- +1 more
Mar 1, 2022
3-D Reconstruction of CT Scan Images in Evaluation of
Active, not recruiting
- Undiagnosed Pulmonary Nodules
- Lung Nodules
- CT Scan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 9, 2022
Common Variable Immunodeficiency and Related Syndromes
Recruiting
- CVID
- XLA
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Obesity Trial (BI 456906, Placebo)
Not yet recruiting
- Obesity
- BI 456906
- Placebo
- (no location specified)
Sep 27, 2023
Middle Cerebral Artery Acute Ischemic Stroke Trial in Poitiers (Multimodal MRI)
Recruiting
- Middle Cerebral Artery Acute Ischemic Stroke
- Multimodal MRI
-
Poitiers, FranceCHU Poitiers
Apr 6, 2022
Biospecimen Acquisition for Myelodysplastic Syndromes
Recruiting
- Myelodysplastic Syndromes
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Hemothorax Caused by Posterior Correction Surgery for Spinal
Completed
- Spinal Deformity
- Hemothorax Postoperative
- posterior correction surgery
-
Ankara, None Selected, TurkeyGazi Üniversitesi
Oct 11, 2022
Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)
Recruiting
- Neuroendocrine Tumor of Pancreas (Disorder)
- Neuroendocrine Tumor Grade 1
- Radiofrequency ablation
-
Marseille, FranceInstitut Paoli Calmettes
Jan 5, 2022
Asthma Trial in San Francisco (Budesonide)
Completed
- Asthma
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 1, 2022
STUDY TO EVALUATE THE SENSITIVITY OF LINDA THERMAL DEVICE
Not yet recruiting
- Device
- +2 more
- Device
- (no location specified)
Aug 30, 2021
Femoral Fracture Trial (Fracture Monitor (implantable device class III))
Not yet recruiting
- Femoral Fracture
- Fracture Monitor (implantable device class III)
-
Homburg, Germany
- +3 more
Jan 30, 2023
Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with
Enrolling by invitation
- Gastric / Gastroesophageal Junction Adenocarcinoma
- envafolimab and lenvatinib combined with paclitaxel-albumin
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Sep 3, 2023
Retrospective Data of Glucagon-like Peptide-1 Participanta With
Recruiting
- Diabetes Mellitus, Type 2
-
Skopje, North MacedoniaNovo Nordisk Investigational Site
Jul 22, 2022
Normal Healthy Subjects Trial in Fair Lawn (HT-6184, HT-6184 Placebo)
Recruiting
- Normal Healthy Subjects
- HT-6184
- HT-6184 Placebo
-
Fair Lawn, New JerseyTKL Research, Inc.
Jul 6, 2022